Skip to main content

Table 3 Statistically Significant Variables at Baseline and after 4 Weeks in the Regression Analysis of the Mean KUSTA Score at 6 Months

From: Early reduction in painful physical symptoms is associated with improvements in long-term depression outcomes in patients treated with duloxetine

a) All patients (N = 2574)

   

Variable

F-value

p-value

Estimate a

≥ 50% reduction in overall pain VAS during the first 4 weeks

158.6

< 0.0001

13.32

Number of weeks unable to work in the last 12 months

40.9

< 0.0001

-0.23

Overall pain VAS at baseline (per 20 mm)

33.9

< 0.0001

-2.34

Any concomitant somatic disease at baseline

30.5

< 0.0001

-5.86

SSI non-painful symptoms subscore at baseline

18.0

< 0.0001

-3.49

Living alone

13.8

< 0.001

-3.89

≥ 50% reduction in the SSI painful symptoms subscore during the first 4 weeks

11.0

< 0.001

6.22

Any baseline psychotropic medication

7.9

0.005

-2.93

Duration of depression (years)

6.1

0.014

-0.12

Mean KUSTA at baseline (per 20 mm)

5.6

0.018

1.47

b) Patients with baseline pain VAS > 30 mm (N = 2053)

   

Variable

F-value

p-value

Estimate a

≥ 50% reduction in overall pain VAS during the first 4 weeks

151.4

< 0.0001

14.74

Number of weeks unable to work in the last 12 months

40.2

< 0.0001

-0.25

Any concomitant somatic disease at baseline

22.1

< 0.0001

-5.98

SSI non-painful symptoms subscore at baseline

16.0

< 0.0001

-3.54

Overall pain VAS at baseline (per 20 mm)

15.0

< 0.001

-2.50

Living alone

13.3

< 0.001

-4.24

Mean KUSTA at baseline (per 20 mm)

9.9

0.002

2.36

≥ 50% reduction in the SSI painful symptoms subscore during the first 4 weeks

8.7

0.003

5.84

Age

4.1

0.044

-0.09

Duration of Depression (years)

3.9

0.048

-0.10

  1. a For binary outcomes (yes/no) the given estimate reflects the average impact on the KUSTA score if the respective factor is present ("yes") compared to the situation where it is not present ("no"), e.g. in this model the mean KUSTA score for a patient living alone is estimated to be 3.89 points lower than for patient not living alone. For continuous outcomes, the estimate reflects the difference in the KUSTA score for each unit increase of the respective covariate, e.g. in this model for each additional year of duration of depression the mean KUSTA score is reduced by 0.12 points.